Vanguard Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$495K Buy
36,758
+11,569
+46% +$144K ﹤0.01% 2186
2026
Q2
$273K Hold
25,189
– – ﹤0.01% 2341
2026
Q1
$319K Buy
+25,189
New +$286K ﹤0.01% 2281

Other funds holding ORIC

Vanguard Asset Management's ORIC Position: Q3 2026 in Review

Vanguard Asset Management increased its Oric Pharmaceuticals (ORIC) stake by 46% in Q3 2026, buying an estimated $144K and bringing the position to 36,758 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Vanguard Asset Management first reported a position in ORIC in Q1 2026 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Vanguard Asset Management held 36,758 shares of Oric Pharmaceuticals worth $495K as of Q3 2026.
  • Vanguard Asset Management bought 11,569 Oric Pharmaceuticals shares in Q3 2026, an estimated $144K.
  • Oric Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2186 holding.
  • Vanguard Asset Management first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.